Suchergebnisse - "Peng, Ye"

PubPharm (3)

1

Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States

enthalten in: Clinical therapeutics | 2023

von Peng, Y. | Wang, L. | Peng, L. | +8

2

Economic Evaluation of Adding Daratumumab to a Regimen of Bortezomib + Dexamethasone in Relapsed or Refractory Multiple Myeloma : Based on the Latest Updated Analysis of CASTOR

enthalten in: Clinical therapeutics | 2020

von Zeng, X. | Peng, L. | Peng, Y. | +2

3

Cost-Effectiveness Analysis of Adding Palbociclib as a Second-Line Endocrine Therapy for HR+/HER2- Metastatic Breast Cancer From the US and Chinese Perspectives

enthalten in: Clinical therapeutics | 2019

von Zhang, Y. | Zeng, X. | Deng, H. | +5

1
[1]